orlistat


Also found in: Medical, Wikipedia.
Related to orlistat: Xenical

or·li·stat

 (ôr′lĭ-stăt′)
n.
A drug, C29H53NO5, that reduces dietary fat absorption by inhibiting the enzyme lipase, used in the management of obesity.

[or(tho)- + li(p)stat(in), naturally occurring lipase inhibitor (lip(ase) + -stat + -in).]

orlistat

(ˈɔːlɪˌstæt)
n
a drug that promotes weight loss
Translations

orlistat

n orlistat m
References in periodicals archive ?
Morris Schambelan, chief of the division of endocrinology, University of San Francisco, said that despite some concerns, orlistat is not systemic and does not have CNS effects.
Orlistat inhibits an enzyme that fuels prostate tumour growth and prevents the disease spreading in mice, scientists discovered.
The currently available categories of medication are phentermine and phendimetrazine, which work primarily through norepinephrine pathways and affect hunger; sibutramine, which is primarily a serotonin reuptake inhibitor and affects satiety; and orlistat, which blocks the absorption of lipids from the gastrointestinal tract.
Por su parte, el orlistat, un farmaco utilizado para bajar de peso, se ha visto que ayuda a prevenir la diabetes tipo II, ya que puede mejorar la tolerancia a la glucosa en los pacientes propensos a esta enfermedad.
The drug, also known as orlistat, works by blocking the digestion of fat.
The recommendation by the National Institute for Clinical Excellence will cost the NHS pounds 12 million a year and could see thousands more patients prescribed Orlistat (marketed by Roche as Xenical).
Table 28: Contraindications, cautions, adverse reactions and drug interactions - orlistat, sibutramine and phentermine 115
THE only clinically proven, safe and effective weight loss drug is called Orlistat (also known as Xenical or Alli).
Online vendors offer a discreet way for people who don't need to lose huge amounts of weight to purchase alternatives to Orlistat, without having to consult a medical professional.
Female health company M Pharmaceutical Inc (CSE: MQ)OTCQB: MPHMF) said on Wednesday that it has received encouraging response from the US Food and Drug Administration (FDA) for its clinical study plan through the 505(b)(2) pathway for its obesity management drug, C-103, reformulated Orlistat, with the assistance of Camargo Pharmaceutical Services.
Similarly, reviewers for the weight loss pill Orlistat claimed they lost twice as much weight (about 30 lbs) as those in clinical trials (about 15 lbs).
The investigators pooled data from 28 studies of phentermine-topiramate (Qsymia) and four other drugs: orlistat (Xenical, Alii), lorcaserin (Belviq), naltrexone-bupropion (Contrave), and liraglutide (Victoza, Saxenda).